BB Biotech AG
Latest statistics and disclosures from BB BIOTECH AG's latest quarterly 13F-HR filing:
- Top 5 stock holdings are INCY, CELG, Ionis Pharmaceuticals, GILD, Radius Health, and represent 50.57% of BB BIOTECH AG's stock portfolio.
- Added to shares of these 10 stocks: Five Prime Therapeutics (+$26.30M), Ionis Pharmaceuticals (+$22.03M), Juno Therapeutics (+$6.99M), Radius Health (+$6.96M), Macrogenics (+$6.32M), Intra Cellular Therapies (+$5.69M), VRTX, Esperion Therapeutics, ALNY, NBIX.
- Started 1 new stock positions in Five Prime Therapeutics.
- Reduced shares in these 6 stocks: INCY (-$52.13M), Tesaro (-$23.08M), CELG (-$14.93M), Kite Pharma, Sage Therapeutics, Avexis.
- BB BIOTECH AG was a net seller of stock by $7.88M.
- BB BIOTECH AG has $3.06B in assets under management (AUM), growing by 13.22%.
BB BIOTECH AG portfolio companies for March 2017 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Price | Last Trade |
|---|---|---|---|---|
| Incyte Corporation (INCY) | 15.26 | 3.49M -10.00% | 133.67 | 138.27 |
| Celgene Corporation (CELG) | 13.59 | 3.34M -3.00% | 124.43 | 137.84 |
| Ionis Pharmaceuticals | 9.81 | 7.46M +7.00% | 40.20 | 0.00 |
| Gilead Sciences (GILD) | 6.16 | 2.77M | 67.92 | 74.39 |
| Radius Health | 5.74 | 4.54M +4.00% | 38.65 | 0.00 |
| Agios Pharmaceuticals | 5.42 | 2.84M | 58.40 | 0.00 |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.21 | 1.46M +2.00% | 109.35 | 166.11 |
| Alexion Pharmaceuticals (ALXN) | 4.88 | 1.23M | 121.24 | 130.74 |
| Neurocrine Biosciences (NBIX) | 4.53 | 3.20M | 43.30 | 48.69 |
| Tesaro | 4.15 | 824582 -15.00% | 153.87 | 0.00 |
| Halozyme Therapeutics (HALO) | 3.29 | 7.75M | 12.96 | 13.63 |
| Regeneron Pharmaceuticals (REGN) | 3.11 | 245000 | 387.51 | 521.22 |
| Sage Therapeutics | 2.26 | 972439 -4.00% | 71.07 | 0.00 |
| Alnylam Pharmaceuticals (ALNY) | 2.08 | 1.24M +4.00% | 51.25 | 83.54 |
| Kite Pharma | 1.90 | 740000 -7.00% | 78.49 | 0.00 |
| Esperion Therapeutics | 1.63 | 1.41M +7.00% | 35.31 | 0.00 |
| Juno Therapeutics | 1.59 | 2.19M +16.00% | 22.19 | 0.00 |
| Macrogenics | 1.38 | 2.26M +17.00% | 18.60 | 0.00 |
| Myovant Sciences | 1.27 | 3.30M +3.00% | 11.74 | 0.00 |
| Alder Biopharmaceuticals | 1.15 | 1.69M | 20.80 | 0.00 |
| Intra Cellular Therapies | 1.02 | 1.93M +22.00% | 16.25 | 0.00 |
| Intercept Pharmaceuticals In | 0.95 | 255719 | 113.10 | 0.00 |
| Five Prime Therapeutics | 0.86 | 727500 NEW | 36.15 | 0.00 |
| Avexis | 0.83 | 332800 -5.00% | 76.03 | 0.00 |
| Prothena | 0.64 | 350000 | 55.79 | 0.00 |
| Novavax (NVAX) | 0.35 | 8.33M | 1.28 | 1.51 |
| Puma Biotechnology Inc Common Stock | 0.30 | 245616 | 37.20 | 0.00 |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.27 | 1.04M | 7.80 | 0.00 |
| Ptc Therapeutics I | 0.22 | 682912 | 9.84 | 0.00 |
| Achillion Pharmaceuticals (ACHN) | 0.18 | 1.28M | 4.21 | 4.27 |
Download CSV 
Past 13F-HR SEC Filings for BB BIOTECH AG
- BB BIOTECH AG 2016 Q4 filed Feb. 14, 2017
- BB BIOTECH AG 2016 Q3 filed Nov. 10, 2016
- BB BIOTECH AG 2016 Q2 filed Aug. 12, 2016
- BB BIOTECH AG 2016 Q1 filed May 12, 2016
- BB BIOTECH AG 2015 Q4 filed Feb. 9, 2016
- BB BIOTECH AG 2015 Q3 filed Nov. 12, 2015
- BB BIOTECH AG 2015 Q2 filed Aug. 12, 2015
- BB BIOTECH AG 2015 Q1 filed May 14, 2015
- BB BIOTECH AG 2014 Q4 filed Feb. 12, 2015
- BB BIOTECH AG 2014 Q3 filed Nov. 13, 2014
- BB BIOTECH AG 2014 Q2 filed Aug. 7, 2014
- BB BIOTECH AG 2014 Q1 filed May 8, 2014
- BB BIOTECH AG 2013 Q4 filed Feb. 12, 2014
- BB BIOTECH AG 2013 Q3 filed Nov. 12, 2013
- BB Biotech AG 2013 Q1 filed May 6, 2013
- BB Biotech AG 2012 Q4 filed Feb. 13, 2013
- BB Biotech AG 2012 Q3 filed Nov. 6, 2012
- BB Biotech AG 2012 Q2 filed Aug. 7, 2012
- BB Biotech AG 2012 Q1 filed May 3, 2012